Lab-grown uterine models from real patient samples to de-risk drug discovery in endometriosis and fibroids
Opal Therapeutics has raised $275K in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Opal Therapeutics's investors include National Science Foundation.
Opal Therapeutics is headquartered in San Francisco, United States.
Lab-grown uterine models from real patient samples to de-risk drug discovery in endometriosis and fibroids
Opal Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Opal Therapeutics — Funding & Investors." VCBacked, September 1, 2024, https://www.vcbacked.co/company/opal-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Opal Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/opal-therapeutics
{{cite web |title=Opal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/opal-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated